Jeremy Levin (Credit: Biotechnology Innovation Organization via Youtube)
March 15, 2021 02:58 PM EDTUpdated March 16, 07:43 AM
People
Pharma

BIO chair slams Trump’s HHS, calls to stop Russ­ian dis­in­for­ma­tion cam­paign on vac­cines

Zachary Brennan

Senior Editor

In a phone in­ter­view on Mon­day, Je­re­my Levin, chair­man of in­dus­try group BIO and CEO of Ovid Ther­a­peu­tics, of­fered up the biotech in­dus­try’s po­si­tion on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times